Disc Medicine Q3 EPS $(1.53) Beats $(1.76) Estimate
Benzinga Newsdesk 2 weeks ago
NewsEarningsEarnings Beats
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Disc Medicine (NASDAQ:IRON) reported quarterly losses of $(1.53) per share which beat the analyst consensus estimate of $(1.76) by 13.07 percent. This is a 13.56 percent increase over losses of $(1.77) per share from
Disc Medicine (NASDAQ:IRON) reported quarterly losses of $(1.53) per share which beat the analyst consensus estimate of $(1.76) by 13.07 percent. This is a 13.56 percent increase over losses of $(1.77) per share from the same period last year.
